Diligence memo · auto-generated · as of July 2, 2026
Orange Grove Bio LLC
Orange Grove Bio LLC looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Orange Grove Bio LLC operates in Biotech / Pharma, based in CINCINNATI.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Orange Grove Bio LLC has raised $17M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $17M on 2022-08-10.
Most recent recorded round closed around 2022-08-10.
Valuation (modeled)modeled
Provath models Orange Grove Bio LLC at approximately $256M (range $34M–$658M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.97× the median modeled value of Series B Biotech / Pharma companies in 2022–2024 (15 peers) — value vs value, same stage and era. Within the normal band (97% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 3.9 yr ago; this sector typically re-raises about every 15 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 71% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 82% of those peers.
Closest niche peers: Carbon Biosciences, Inc., Slingshot Biosciences, Inc., Nueva Bio LLC, Telesis Bio Inc., Turn Biotechnologies, Inc..
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.